Drug Target: Identification and Mechanism of Action

Dear Colleagues,

Drug target identification and mechanism of action (MoA) studies are essential for the development of novel drugs. The target is the molecule or cellular process that the drug will interact with to produce its desired effect. The MoA is the biochemical or cellular pathway via which the drug exerts its effect. The aims of this Special Issue are as follows:

• Provide a forum for the latest advances in drug target identification and MoA studies.
• Promote interdisciplinary collaboration between chemists, biologists, and medicinal chemists.
• Highlight the importance of drug target identification and MoA studies in the development of new drugs to treat diseases.

Topics of interest for this Special Issue include, but are not limited to, the following:

• The mechanism of action of new and existing drugs;
• The discovery and development of new drug targets;
• The design and optimization of new drug molecules;
• The use of biochemical, genetic, and cellular approaches to identify drug targets;
• The use of computational methods to predict drug targets;
• The study of the MoA of known drug targets;
• The development of new methods for drug target identification and MoA studies.

Dr. Srijan Acharya
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pharmacology
• drug discovery
• drug targets
• receptors function
• target validation
• chemical biology
• lead optimization